| Literature DB >> 35928915 |
Qudsia Yousafi1, Shabana Bibi2,3, Shahzad Saleem1, Abrar Hussain1, Mohammad Mehedi Hasan4, Maria Tufail1, Amina Qandeel1, Muhammad Saad Khan1, Sania Mazhar5, Maha Yousaf6, Mahmoud Moustafa7,8, Mohammed Al-Shehri7, Mohammad Khalid9, Atul Kabra10.
Abstract
Phytopathogenic fungi are serious threats in the agriculture sector especially in fruit and vegetable production. The use of plant essential oil as antifungal agents has been in practice from many years. Plant essential oils (PEOs) of Cuminum cyminum, Trachyspermum ammi, Azadirachta indica, Syzygium aromaticum, Moringa oleifera, Mentha spicata, Eucalyptus grandis, Allium sativum, and Citrus sinensis were tested against Fusarium oxysporum. Three phase trials consist of lab testing (MIC and MFC), field testing (seed treatment and foliar spray), and computer-aided fungicide design (CAFD). Two concentrations (25 and 50 μl/ml) have been used to asses MIC while MFC was assessed at four concentrations (25, 50, 75, and 100 μl/ml). C. sinensis showed the largest inhibition zone (47.5 and 46.3 m2) for both concentrations. The lowest disease incidence and disease severity were recorded in treatments with C. sinensis PEO. Citrus sinensis that qualified in laboratory and field trials was selected for CAFD. The chemical compounds of C. sinensis PEO were docked with polyketide synthase beta-ketoacyl synthase domain of F. oxysporum by AutoDock Vina. The best docked complex was formed by nootkatone with -6.0 kcal/mol binding affinity. Pharmacophore of the top seven C. sinensis PEO compounds was used for merged pharmacophore generation. The best pharmacophore model with 0.8492 score was screened against the CMNP database. Top hit compounds from screening were selected and docked with polyketide synthase beta-ketoacyl synthase domain. Four compounds with the highest binding affinity and hydrogen bonding were selected for confirmation of lead molecule by doing MD simulation. The polyketide synthase-CMNPD24498 showed the highest stability throughout 80 ns run of MD simulation. CMNPD24498 (FW054-1) from Verrucosispora was selected as the lead compound against F. oxysporum.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35928915 PMCID: PMC9345698 DOI: 10.1155/2022/5347224
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Figure 1Minimum inhibitory concentration of different concentrations of plant essential oils against Fusarium oxysporum.
Figure 2Minimum fungicidal concentration activity of different plant essential oils against Fusarium oxysporum.
Figure 3Effect of foliar application of different concentrations of plant essential oils on percent disease incidence of Fusarium oxysporum in tomato.
Effect of foliar application of different concentrations of plant essential oils on percent disease severity of Fusarium oxysporum in tomato.
| No. | Plant essential oil concentrations( | Total leaf area (cm2) | Infested leaf area (cm2) | PDS∗∗ | Infested leaf area (cm2) | PDS∗∗ | Reduction | DSS∗∗∗ | PDI∗∗∗∗ | PEDC∗∗∗∗∗ |
|---|---|---|---|---|---|---|---|---|---|---|
| T1 |
| 23.2 | 1.5 | 5.7 ± 0.01cd∗ | 0.9 | 3.7 ± 0.02c∗ | 2.6 | 2-1 | 40-20 | 60-80 |
| T2 |
| 22.7 | 1.3 | 6.5 ± 0.01c | 0.9 | 3.9 ± 0.02c | 2.0 | 2-1 | 40-20 | 60-80 |
| T3 |
| 23.1 | 2.3 | 10.0 ± 0.03b | 2.6 | 11.3 ± 0.03b | -1.3 | 3-4 | 20 | 80 |
| T4 |
| 23.3 | 3.0 | 12.9 ± 0.01b | 2.8 | 12.0 ± 0.02b | 0.9 | 4 | 60 | 40 |
| T5 |
| 22.6 | 0.7 | 3.1 ± 0.01d | 0.6 | 2.7 ± 0.01d | 0.4 | 1 | 20 | 80 |
| T6 |
| 22.6 | 1.0 | 4.4 ± 0.02cd | 0.8 | 3.5 ± 0.02cd | -1.8 | 1 | 20 | 80 |
| T7 | Ridomil Gold WG | 22.8 | 0.5 | 2.2 ± 0.02d | 0.3 | 1.5 ± 0.03de | 0.7 | 1 | 20 | 80 |
| T8 | Ethanol | 23.1 | 17.0 | 73.6 ± 0.00a | 16.0 | 69.3 ± 0.02a | 4.3 | 5 | 100 | 0 |
|
|
|
|
∗Values sharing the same letters in column are not significantly different. ∗∗Percent disease severity. ∗∗∗Disease severity scale. ∗∗∗∗Percent disease index. ∗∗∗∗∗∗Percent efficacy of disease control.
Effect of seed treatment of different plant essential oils on percent disease severity of Fusarium oxysporum in tomato.
| No. | Plant essential oils (60 | Total leaf area (cm2) | Infected area (cm2) | PDS∗∗ | DSS∗∗∗ | PDI∗∗∗∗ | PECD∗∗∗∗∗ | %incidence |
|---|---|---|---|---|---|---|---|---|
| 1 |
| 22.0 | 1.1 | 3.64 ± 0.1cd∗ | 1 | 40 | 60 | 2.6.±0.1c |
| 2 |
| 21.7 | 2.7 | 12.44 ± 0.0b | 3 | 60 | 40 | 4.5 ± 0.2b |
| 3 |
| 21.6 | 0.8 | 2.11 ± 0.3d | 1 | 20 | 80 | 1.5 ± 0.2d |
| 4 | Ridomil Gold WG | 22.0 | 0.3 | 1.36 ± 0.1d | 1 | 20 | 80 | 1.0 ± 0.2d |
| 5 | Distilled water | 23.0 | 19.0 | 82.61 ± 0.1a | 5 | 100 | 0 | 9.6 ± 0.0a |
|
|
|
|
∗Values sharing the same letters in column are not significantly different. ∗∗Percent disease severity. ∗∗∗Disease severity scale. ∗∗∗∗Percent disease index. ∗∗∗∗∗∗Percent efficacy of disease control.
Figure 4Tomato plant phenotypic response to the seed treatment by plant essential oils.
Figure 5Refined 3D model of polyketide synthase beta-ketoacyl synthase domain in Fusarium oxysporum and model evaluation results: (a) refined 3D model, (b) Ramachandran plot, (c) ERRAT score, and (d) verify 3D score.
Properties of chemical compounds of Citrus sinensis essential oil and results of docking with polyketide synthase beta-ketoacyl synthase domain in Fusarium oxysporum.
| No. | Compounds | PubChem CID | MW (g/mol) | HBD | HBA | nRTB | Logp | BA (kcal/mol) | H-bond |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| 1 |
| 14896 | 136.23 | 1 | 0 | 0 | 3.1 | -4.3 | 0 |
| 2 |
| 31253 | 142.27 | 1 | 0 | 0 | 4.3 | -3.8 | 0 |
| 3 | Limonene | 22311 | 136.23 | 2 | 0 | 1 | 3.4 | -5.8 | 0 |
| 4 | Sabinene | 18818 | 136.23 | 1 | 0 | 1 | 3.1 | -4.8 | 0 |
|
| |||||||||
| 5 |
| 17100 | 154.25 | 1 | 1 | 1 | 1.8 | -4.7 | 1 |
| 6 | (Z)-p-Menth-2-en-1-ol | 13918681 | 154.25 | 1 | 1 | 1 | 2.3 | -6.1 | 1 |
| 7 | Neral | 643779 | 152.23 | 0 | 1 | 4 | 3.0 | -5.9 | 1 |
|
| |||||||||
| 8 |
| 92313 | 204.35 | 2 | 0 | 1 | 4.3 | -5.7 | 0 |
| 9 |
| 5281517 | 204.35 | 1 | 0 | 7 | 6.2 | -5.0 | 0 |
| 10 |
| 6452086 | 218.33 | 0 | 1 | 1 | 3.8 | -5.8 | 0 |
| 11 | Caryophyllene oxide | 1742210 | 220.35 | 0 | 1 | 0 | 3.6 | -6.2 | 0 |
| 12 | Germacrene B | 5281519 | 204.35 | 2 | 0 | 1 | 4.7 | -6.2 | 0 |
|
| |||||||||
| 13 | Elemol | 92138 | 222.37 | 1 | 1 | 3 | 4.4 | -5.3 | 1 |
| 14 | Nootkatone | 1268142 | 218.33 | 0 | 1 | 1 | 3.9 | -6.0 | 2 |
|
| |||||||||
| 15 | Citronellyl acetate | 9017 | 198.3 | 0 | 2 | 7 | 3.8 | -4.8 | 1 |
| 16 | Neryl acetate | 1549025 | 196.29 | 0 | 2 | 6 | 3.5 | -4.5 | 1 |
MW = molecular weight; HBD = hydrogen bond donor; HBA = hydrogen bond acceptor; nRTB = number of rotatable bonds; BA = binding affinity.
Figure 6Pharmacophore features of selected, polyketide synthase beta-ketoacyl synthase domain in Fusarium oxysporum inhibitor, compounds from Citrus sinensis plant essential oils.
Properties of marine life-derived compounds and results of docking with polyketide synthase beta-ketoacyl synthase domain in Fusarium oxysporum.
| No. | CMNPD ID | IUPAC name | MW (g/mol) | Logp | HBA | HBD | nRB | nAR | BA (kcal/mol) | H-bond | Source species |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 91 | 2-[(1R,2S)-1,2-Dimethyl-3-methylidenecyclopentyl]-5-methylphenol | 195.99 | 3.792 | 1 | 0 | 1 | 1 | -6.9 | 4 |
|
| 2 | 538 | (1S,2R,3R,5R,6R,7R,8R)-5-[(4E)-6-Hydroxy-6-methylhepta1,4-dien-2-yl]-2,8-dimethyltricyclo[5.3.0.02,6]decan-3-ol | 275.01 | 4.488 | 2 | 0 | 4 | 0 | -4.1 | 3 |
|
| 3 | 1118 | (3bR,6S,7S,9aR)-7-Hydroxy-6-(hydroxymethyl)-3b,6,9a-trimethyl-4,5,5a,7,9,9b,10,11-octahydronaphtho[2,1-e][2]benzofuran-8-one | 303.98 | 3.25 | 4 | 0 | 1 | 1 | -6.5 | 2 |
|
| 4 | 2024 | (1Z)-1-[(3S,3aS,7S,7aS)-3,7-Dimethyl-1,2,3,3a,5,6,7,7a-octahydroinden-4-ylidene]-2-methylpropan-2-ol | 198.01 | 4.752 | 1 | 0 | 1 | 0 | -5.4 | 1 |
|
| 5 | 2365 | (1R,2R,4S)-4-Methyl-1-propan-2-yl-3,4-dihydro-2H-naphthalene-1,2,6-triol | 215.98 | 1.167 | 3 | 0 | 1 | 1 | -5.1 | 2 |
|
| 6 | 2924 | 2-[(1R,3E,7E,11E)-4,8,12-Trimethylcyclotetradeca-3,7,11-trien-1-yl]propane-1,2-diol | 271.99 | 4.881 | 2 | 0 | 2 | 0 | -5.8 | 2 |
|
| 7 | 4785 | 3-Hydroxy-3,5,5-trimethyl-7-propan-2-yl-2,4-dihydroinden-1-one | 211.99 | 2.328 | 2 | 0 | 1 | 0 | -5.8 | 1 |
|
| 8 | 5394 | [(1R,2aR,3S,4aR,5R,6S,7R,8R,8aR)-3,6-Dibromo-7-hydroxy-2a,4a,5,8-tetramethyl-1,2,3,4,5,6,7,8-octahydrocyclobuta[i]inden-1-yl] acetate | 409.82 | 4.625 | 3 | 0 | 2 | 0 | -5.5 | 0 |
|
| 9 | 15648 | (9Z,11E)-Tricyclo[12.3.1.12,6]nonadeca-1(17),2,4,6(19),9,11,14(18),15-octaene-3,8,17-triol | 275.98 | 2.135 | 3 | 0 | 0 | 2 | -6.7 | 0 |
|
| 10 | 15845 | 6,7,9a-Trimethyl-1,3,5,5a,6,8,9,10a-octahydrofuro[3,4-b][1] benzoxepin-7-ol | 227.98 | 1.386 | 3 | 0 | 0 | 0 | -5.6 | 0 |
|
| 11 | 18682 | (1S,4R,4aS,8aS)-6-(Hydroxymethyl)-4-(2-hydroxypropan-2-yl)-1-methyl-3,4,4a,7,8,8a-hexahydro-2H-naphthalen-1-ol | 230 | 0.841 | 3 | 0 | 2 | 0 | -5.7 | 3 |
|
| 12 | 19958 | [(1S,3aS,4R,8S,8aR)-8-Ethyl-1,4-dimethyl-3a,5,6,7,8,8a-hexahydro-1H-azulen-4-yl] methanol | 198.01 | 4.216 | 1 | 0 | 2 | 0 | -6.7 | 1 |
|
| 13 | 20001 | (1S,3aR,4S,8aS)-1,4-Dimethyl-7-propan-2-yl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol | 214.01 | 2.613 | 2 | 0 | 1 | 0 | -5.5 | 0 |
|
| 14 | 20352 | (1S,3aS,4S,7S)-1,4-Dimethyl-7-propan-2-yl-3,4,5,6-tetrahydro-2H-azulene-1,3a,7-triol | 227.98 | 0.744 | 3 | 0 | 1 | 0 | -5.8 | 7 |
|
| 15 | 20360 | (3S,4E,6S,8Z,11S,16R)-6,16-Dihydroxy-8-(hydroxymethyl)-4,15,15-trimethyltricyclo [9.3.1.13,14] hexadeca-1(14),4,8-trien-2-one | 306 | 0.45 | 4 | 0 | 1 | 0 | -6.3 | 1 |
|
| 16 | 22108 | (1S,4S,5S,9R)-8-(Hydroxymethyl)-4-(1-hydroxypropan-2-yl)-1-methylspiro [4.5] dec-7-en-9-ol | 228.99 | 2.351 | 3 | 0 | 3 | 0 | -5.1 | 5 |
|
| 17 |
|
|
|
|
|
|
|
|
|
|
|
| 18 | 24574 | [(1S,2S,4E,6R,7E,9R)-1,6-Dihydroxy-8-(hydroxymethyl)-4,11,11-trimethyl-2-bicyclo [7.2.0] undeca-4,7-dienyl] acetate | 284.98 | 0.006 | 5 | 0 | 3 | 0 | -5.6 | 5 |
|
| 19 | 26841 | (1R,2S,5R,8R,9R)-1,4,4,8-Tetramethyl-12-oxatricyclo [6.3.1.02,5] dodecan-9-ol | 214.01 | 3.563 | 2 | 0 | 0 | 0 | -5.2 | 1 |
|
| 20 | 26845 | (3aS,5S,5aR,6S,8S)-5a,6,8-Trihydroxy-3a-methoxy-1,5,8-trimethyl-4,5,6,7-tetrahydroazuleno[6,5-b] furan-2-one | 287.97 | -0.833 | 6 | 0 | 1 | 0 | -6.0 | 0 |
|
| 21 | 28987 | 9-Hydroxy-3-(1-hydroxyethyl)-3H-2-benzoxepin-1-one | 207.98 | 0.862 | 4 | 0 | 1 | 1 | -5.5 | 4 |
|
| 22 | 30788 | (1S,2R,3aR,8aS)-1-(2-hydroxypropan-2-yl)-3a,6-Dimethyl-2,3,4,7,8,8a-hexahydroazulene-1,2-diol | 228.99 | 3.074 | 3 | 0 | 1 | 0 | -5.7 | 2 |
|
| 23 | 30789 | (1S,2R,3aR,4R,8aS)-3a,6-Dimethyl-1-propan-2-yl-2,3,4,7,8,8a-hexahydroazulene-1,2,4-triol | 228.99 | 1.947 | 3 | 0 | 1 | 0 | -6.2 | 2 |
|
| 24 | 20359 | (3S,4E,6R,7S,11R,16R)-6,7,16-Trihydroxy-4,15,15-trimethyl-8-methylidenetricyclo [9.3.1.13,14] hexadeca-1(14),4-dien-2-one | 306 | 1.197 | 4 | 0 | 0 | 0 | -5.4 | 6 |
|
| 25 | 11537 | [(1S,8aS)-5,5,8a-Trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl] methanol | 195.99 | 3.067 | 1 | 0 | 1 | 0 | -5.6 | 0 |
|
| 26 | 11370 | (1R,3aR,4R,8aR)-1-Methoxy-1,4-dimethyl-7-propan-2-yl-2,3,3a,5,6,8a-hexahydroazulen-4-ol | 226.01 | 3.132 | 2 | 0 | 2 | 0 | -5.8 | 0 |
|
| 27 | 5390 | 2-[(1R,3R,4S)-4-Chloro-1,3-dimethylcyclohexyl]-5-methylphenol | 230.96 | 3.789 | 1 | 0 | 1 | 1 | -6.7 | 0 |
|
MW = molecular weight; HBD = hydrogen bond donor; HBA = hydrogen bond acceptor; nRTB = number of rotatable bonds; BA = binding affinity; nAR = number of aromatic rings.
Figure 7(a–h) Three-dimensional (3D) and two-dimensional (2D) interactions of polyketide synthase beta-ketoacyl synthase domain-CMNPD24498 at different time slots during MD simulation.
Figure 8MD simulation results of polyketide synthase beta-ketoacyl synthase domain-CMNPD24498 complex.